Medicine continues to be plagued by poorly reproducible studies. The storyline is familiar. First, a very positive study is released in a major medical journal, with great fanfare. This leads to widespread changes in practice. Decades later, it becomes clear that the study was incorrect. Recently a new tool was developed to help understand the reproducibility of clinical studies: the fragility index. This post will analyze the NINDS trial from the perspective of its fragility index.
EMCrit by Josh Farkas.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/29iGZYu
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου